N-(methylsulfonyl)-2-(1,1,2,2,3,3,4,4-d8-4-((5,6-diphenylpyrazin-2-yl)(isopropyl)amino)butoxy)acetamide

Selexipag-d8 is a labelled version of Selexipag (S253150) which is an orally available, highly selective, long-acting prostacyclin (IP) receptor agonist prodrug. It is a potential drug for the treatment of various vascular disorders such as pulmonary arterial hypertension and arteriosclerosis obliterans.